Previous Article | Next Article ![]()
Journal of Virology, March 2001, p. 2597-2603, Vol. 75, No. 6
Collegium Budapest, Institute for Advanced
Study, 1014 Budapest, Hungary,1 and
Theoretical Biology, Utrecht University, 3584 CH Utrecht, The
Netherlands2
Received 19 July 2000/Accepted 20 December 2000
Kinetic parameters of human immunodeficiency virus type 1 (HIV-1)
and hepatitis C virus (HCV) infections have been estimated from plasma
virus levels following perturbation of the chronically infected
(quasi-) steady state. We extend previous models by also considering
the large pool of virus localized in the lymphoid tissue (LT)
compartment. The results indicate that the fastest time scale of HIV-1
plasma load decay during therapy probably reflects the clearance rate
of LT virus and not, as previously supposed, the clearance rate of
virus in plasma. This resolves the discrepancy between the clearance
rate estimates during therapy and those based on plasma apheresis
experiments. In the extended models plasma apheresis measurements are
indeed expected to reflect the plasma decay rate. We can reconcile all
current HIV-1 estimates with this model when, on average, the clearance
rate of virus in plasma is approximately 20 day
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.6.2597-2603.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Release of Virus from Lymphoid Tissue Affects Human
Immunodeficiency Virus Type 1 and Hepatitis C Virus Kinetics in
the Blood
1, that of
LT virus is approximately 3 day
1, and the death rate of
virus-producing cells is approximately 0.5 day
1. The fast
clearance in the LT compartment increases current estimates for total
daily virus production. Because HCV is produced in the liver, we let
virus be produced into the blood compartment of our model. The results
suggest that extending current HCV models with an LT compartment is not
likely to affect current estimates for kinetic parameters and virus
production. Estimates for treatment efficacy might be affected, however.
*
Corresponding author. Mailing address: Collegium
Budapest, Institute for Advanced Study, Szentháromság u. 2, 1014 Budapest, Hungary. Phone: 36 1 224 8306. Fax: 36 1 224 8310. E-mail: muller_v{at}ludens.elte.hu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»